Moreover, hypertension itself promotes the occurrence of CAD by increasing blood pressure and damaging the vascular endothelium, while whether CYP2C19 gene polymorphisms interact with the pathological and physiological processes of hypertension to further amplify or weaken the risk of CAD remains a scientific issue that needs to be clarified in current research. Here, CYP2C19 is linked to hypertensive disorder.